Passweg, J R <br/><br/>
High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation.  [electronic resource] 

 -  Bone marrow transplantation  Sep 2002 
 - 267-71 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1703671  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antigens, CD34<br/>Antilymphocyte Serum--administration & dosage<br/>CD3 Complex<br/>Cell Count<br/>Cyclophosphamide--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Graft Survival<br/>Hematologic Neoplasms--mortality<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Humans<br/>Lymphocyte Depletion<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Transplantation Conditioning--methods<br/>Transplantation, Homologous--methods<br/>Treatment Outcome